Navigation Links
Disparities in heart health to be addressed by national leaders at women's health summit
Date:11/21/2011

WHAT:

The Cardiovascular Research Foundation (CRF) will sponsor the Women's Heart Health Summit: "In Pursuit of Excellence: Improving Cardiovascular Outcomes in Women." The goal of the meeting is to examine current prevention, treatment, and key research issues to collectively identify opportunities and recommendations that will lead to improved cardiovascular outcomes in women. The panel will explore the following issues:

  • Is there gender bias in diagnoses?
  • Are there physiological factors at play?
  • Why do women often not fare as well as men given the same treatments and therapies?
  • What do women need to know to monitor their own health effectively?

WHEN:
11:00 AM 2:00 PM
Friday, December 9, 2011

WHERE:
The Princeton Club
15 West 43rd Street
New York, NY

WHO:

The Summit will feature a keynote address on the current state of heart disease in women by Cindy L. Grines, MD, Vice President of Academic and Clinical Affairs of the Heart and Vascular Institute at the Detroit Medical Center.

Led by Summit Chair, Roxana Mehran, MD, the Summit will bring together top national experts in research, academia, and health policy to examine the importance of gender in cardiovascular disease research:

Advances in Heart Failure Treatments in Women: Has Device Therapy Made a Difference?
Deborah D. Ascheim, MD
Mount Sinai Medical Center

The American Heart Association's Efforts to Fight Heart Disease in Women
Mary Ann McLaughlin, MD
Mount Sinai Medical Center
American Heart Association, NY Chapter

Inclusion of Women in Clinical Trials: How Can We Improve This?
Karen A. Hicks, MD
US Food and Drug Administration

Patient and Caretaker (Family) Education
Lori Mosca, MD, MPH, PhD
Columbia University Medical Center

Public Awareness and Patient Support: Progress Made Through WomenHeart
Lisa M. Tate
WomenHeart: The National Coalition for Women with Heart Disease

PVD in Women: Are There Any Gaps?
Jeffrey W. Olin, DO
Mount Sinai School of Medicine

Role of Intravascular Imaging in Women: What Can We Learn from Multimodality Imaging?
Annapoorna S. Kini, MBBS
Mount Sinai Medical Center

The Role of Genetic Biomarkers in Enhancing Diagnosis of Coronary Disease in Women
Alexandra Lansky, MD
Yale School of Medicine

Update on Progress Made on Gender-Based Outcomes
Suzanne Haynes, PhD
US Department of Health and Human Services

Use of Existing Databases to Evaluate Outcomes in Women: The WIN NCDR Initiative
Roxana Mehran, MD
Mount Sinai Medical Center

Why Are D2B Times Still Higher in Women Presenting with Acute Myocardial Infarction?
Cindy L. Grines, MD
Detroit Medical Center

WHY:

Research has demonstrated that there are significant disparities in heart health between men and women. Too few people realize the staggering toll cardiovascular disease has on women. Over the past 40 years, there has been a marked reduction in U.S. heart disease deaths in men, but reductions in women have continued to lag behind. More needs to be done to provide women with the knowledge and tools they need to take positive action to reduce their risk of heart disease, as well as to drive the discovery and investigation of new and innovative therapies for women.

HOW TO REGISTER:

Media may apply for registration by contacting Judy Romero at 646-434-46008 or jromero@crf.org.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Racial Disparities Still Exist for Kidney Recipients, Study Finds
2. Disparities in heart health between men and woman to be addressed by national leaders
3. Survival disparities in African-American and white colo-rectal cancer patients
4. Where Folks Live Plays Role in Health Disparities: Study
5. Place, not race, may be a larger determinant of health disparities
6. Physiology of cardiovascular disease: Gender disparities
7. New UNC Center for Diabetes seeks to reduce health disparities
8. $1.1 million grant targets disparities among medical researchers
9. Modeling disparities may help with cervical cancer prevention
10. NCI awards $19.3m for multisite investigation of cancer disparities
11. Report finds large state disparities in progress against colorectal cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... ... Area in Alabama are expected to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. ... scholarship funds for area students and operating support to UNCF-member institutions, including Miles ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... announces the launch of its 60-day free trial program for all of the ... make the offer a truly hassle free experience. , FlexiSpot’s unique desktop risers ...
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame to ... Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to ... drug plan (Part D) need to make changes during this period order for their ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a ... in the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. ... their education, experience, and professional associations. , One the most frequently honored ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 /PRNewswire/ ... ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic ... safety and tolerability profile of ropeginterferon alfa-2b versus HU ... the ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing ... to present this data to the FDA as it seeks ...
(Date:12/4/2016)... -- Sickle cell disease (SCD) is an inherited chronic ... get stuck in veins and block blood flow, which ... leading to death. Each year, approximately 300,000 people around ... them lack access to comprehensive care or effective treatment ... SCD, a pill called hydroxyurea approved more than a ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology: